No. 360 Detailed Review Paper on In Vitro Test Addressing Immunotoxicity With a Focus on Immunosuppression
No. 359 Study Report and Preliminary Guidance on the Adaptation of the In Vitro micronucleus assay (OECD TG 487) for Testing of Manufactured Nanomaterials
No. 358 Detailed Review Paper on the miniaturised versions of the bacterial reverse gene mutation test
No. 357 Supporting document to the Genomic Allergen Rapid Detection Test Method for Skin Sensitisation (GARD™skin), described in Test Guideline 442E
No. 356 Performance Standards for the Assessment of Proposed Similar or Modified in Vitro Phototoxicity: Reconstructed Human Epidermis (RhE) Test Methods for Testing of Topically Applied Substances, as described in Test Guideline 498
No. 355 Peer Review Report- SkinEthicTM Human Corneal Epithelium Time-to-Toxicity Test for Eye irritation
No. 354 Supporting Document for Evaluation and Review of Test Guideline 467 on Defined Approaches (DAs) for Serious Eye Damage / Eye Irritation
No 268: Report of the Peer Review Panel for the IL-8 Luciferase (IL-8) Assay for in vitro skin sensitisation
No 267: Validation report for the international validation study on the IL-8 Luc assay as a test evaluating the skin sensitizing potential of chemicals conducted by the IL-8 Luc Assay
No 265: Background Review Document Supporting the Development of the Test Guideline 433 on Acute Inhalation Toxicity - Fixed Concentration Procedure Harmonised Submission
No 263: Guidance Document on an Integrated Approach on Testing and Assessment (IATA) for Serious Eye Damage and Eye Irritation
No 208: BHAS 42 cell transformation assay validation study report
No 207: New scoping document on in vitro and ex vivo assays for the identification of modulators of thyroid hormone signalling
No 203: Guidance document on an integrated approach on testing and assessment (IATA) for skin corrosion and irritation
No 199: Weight of evidence assessment for the skin sensitisation potential of 4-isopropylaniline (Cumidine, CAS 99-88-7)
No 198: Report on statistical issues related to OECD test guidelines (tgs) on genotoxicity
No 197: Peer review report of the JACVAM initiative international validation studies of the in vivo rodent alkaline comet assay for the detection of genotoxic carcinogens
No 196: Report of the JACVAM initiative international validation studies of the in vivo rodent alkaline comet assay for the detection of genotoxic carcinogens
No 195: Report of the JACVAM initiative international pre-validation studies of the in vivo rodent alkaline comet assay for the detection of genotoxic carcinogens
No 192: Assessing the risk of chemicals to children’s health: An OECD-wide survey
No 190 plus Addendum: Summary document on the Statistical Performace of Methods in OECD Test Guideline 431 for Sub-Categorisation
No 189: Streamlined summary document supporting OECD guideline 437on the bovine corneal opacity and permeability for eye irritation/corrosion
No 188: Streamlined summary document supporting OECD test guideline 438 on the isolated chicken eye for eye irritation/corrosion: Part 1; Part 2
No 180: Streamlined summary document related to the fluorescein leakage (Fl) test method for identification of ocular corrosives and severe irritants (TG 460)
No 176: Report on the retrospective analysis of 2-generation reprotoxicity data
No 174: Performance standards for the BG1Luc ER TA transactivation method to detect estrogen receptor antagonists
No 173: Performance standards for stably transfected transactivation in vitro assays to detect estrogen agonists for TG 455
No 168: The adverse outcome pathway for skin sensitisation initiated by covalent binding to proteins: Part 1, Part 2
No 166: SIDS initial assessment profiles agreed in the course of the OECD HPV Chemicals Programme from 1993 to 2011:
Part 1; Part 2; Part 3; Part 4; Part 5; Part 6
No 163: Peer review report related to three cell transformation assays and agreement of the Working Group of the National Coordinators of the Test Guidelines Programme on the follow-up to the peer review
No 161: Peer review report for the validation of the stably transfected transcriptional activation assay for the detection androgenic and anti-androgenic activity of chemicals (2011)
No 160: Guidance document on the bovine corneal opacity and permeability (Bcop) and isolated chicken eye (Ice) test methods: Collection of tissues for histological evaluation and collection of data on non-severe irritants
No 159: Validation report for the skin irritation test method using LabCyte EPI-MODEL24
No 156: Guidance notes on dermal absorption
No 155: Peer review report of the validation of the skin irritation test using Labcyte Epi-Model 24
No 153: Guidance document for the derivation of an acute reference concentration (Arfc)
No 151: Guidance document supporting OECD test guideline 443 on the extended one-generation reproductive toxicity test
No 149: Validation report of the Balb/c 3T3 cell transformation assay (2011)
No 147: Syrian hamster embryonic (SHE) cell PH 7.0 cell transformation assay prevalidation study report (2011)
No 146: Syrian hamster embryonic (SHE) cell PH 6.7 cell transformation assay prevalidation study report (2011)
No 145: Transgenic rodent somatic and germ cell gene mutation assays: Retrospective performance assessment
No 137: Explanatory background document to the OECD test guideline on in vitro skin irritation testing
No 133: Peer review report for the H295R Cell-based assay for steroidogenesis
No 132: Report of the multi-laboratory validation of the H295R steroidogenesis assay to identify modulators
No 129: Guidance document on using cytotoxicity tests to estimate starting doses for acute oral systematic toxicity tests
No 125: Guidance document on histopathology for inhalation toxicity studies, supporting TG 412 (Subacute inhalation toxicity: 28-day study) and TG 413 (Subchronic inhalation toxicity: 90-day study)
No 124: Guidance for the derivation of an acute reference dose
No 117: Guidance document 117 on the current implementation of internal triggers in test guideline 443 for an extended one generation reproductive toxicity study, in the United States and Canada
No 116: Guidance document 116 on the conduct and design of chronic toxicity and carcinogenicity studies, supporting test guidelines 451, 452 and 453 - second edition (2011)
No 115: Guidance document on the weanling hershberger bioassay in rats: A short-term screening assay for (Anti) androgenic properties
No 114: Performance assessment of different cytotoxic and ctyostatic measures for the in vitro micronucleus test (MNVIT): Summary of results in the collaborative trial
No 113: Report of the focus session on current and forthcoming approaches for chemical safety and animal welfare
No 110: Report of the validation peer review for the weanling hershberger bioassay and agreement of the Working of National Coordinators of the Test Guidelines Programme on the follow-up of this report
No 108: Report of the validation of the hershberger bioassay (Weanling Model)
No 106: Guidance document for histologic evaluation of endocrine and reproductive tests in rodents
No 105: Report on biostatistical performance assessment of the draft TG 436 acute toxic class testing method for acute inhalation toxicity
No 104: Performance assessment: Comparison of 403 and CXT protocols via simulation and for selected real data sets
No 103: Detailed review paper on transgenic rodent mutation assays [Annexes]
No 97: Detailed review paper on the use of metabolising systems for in vitro testing of endocrine disruptors
No 90: Background review document on the rodent hershberger bioassay
No 89: Retrospective performance assessment of the test guideline 426 on developmental neurotoxicity
No 86: Report of the OECD validation of the rodent hershberger bioassay - Phase 2: Testing of androgen agonists, androgen antagonists and a 5 α-reductase inhibitor in dose response studies by multiple laboratories
No 85: Report of the validation peer review for the hershberger bioassay, and the agreement of the Working Group of the National Coordinators of the Test Guidelines Programme on the follow-up of this report
No 83: Summary report of the peer review panel on the stably transfected transcriptional activation assay for detecting estrogenic activity of chemicals, and agreement of the Working Group of National Coordinators of Test Guidelines Programme on the follow-up of this report
No 81: Summary report of the validation peer review for the updated test guideline 407, and agreement of the Working Group of the National Coordinators of the Test Guidelines Programme on the follow-up of this report
No 73: Report of the validation of the rat hershberger assay - Phase 3: Coded testing of androgen agonists, androgen antagonists and negative reference chemicals by multiple laboratories. Surgical castrate model protocol.
No 71: Guidance document on the uterothrophic bioassay - Procedure to test for antioestrogenicity (Korean Version)
No 68: Summary report of the uterothropic bioassay peer review panel, including assessment of the Working Group of the National Coordinators of the Test Guidelines Programme on the follow-up of this report
No 67: Report of the uterotrophic bioassay: Additional data supporting the test guideline on the uterotrophic bioassay in rodents
No 66: OECD report of the validation of the rodent uterotrophic bioassay - Phase 2: Testing of potent and weak oestrogen agonists by multiple laboratories
No 65: OECD report of the initial work towards the validation of the rodent uterothophic assay - Phase 1
No 62: Final OECD report of the initial work towards the validation of the rat hershberger assay - Phase 1: Androgenic response to testosterone propionate, and anti-androgenic effects of flutamide
No 59: Report of the validation of the updated test guideline 407 - Repeat dose 28-day oral toxicity study in laboratory rats [Annexes]
No 57: Detailed review paper on thyroid hormone disruption assays
No 43: Guidance document on mammalian reproductive toxicity testing and assessment
No 39: Second Edition - Guidance Document on Inhalation Toxicity Studies
No 38: Detailed background review of the uterotrophic bioassay [References]
No 35: Guidance notes for analysis and evaluation of chronic toxicity and carcinogenicity studies
No 34: Guidance document on the validation and international acceptance of new or updated test methods for hazard assessment
No 32: Guidance notes for analysis and evaluation of repeat-dose toxicity studies
No 31: Detailed review paper on cell transformation assays for detection of chemical carcinogens
No 28: Guidance document for the conduct of skin absorption studies
No 26: Revised analysis of responses received from Member Countries to the questionnaire on data requirements for acute oral toxicity
No 25: Classification systems for specific target organ toxicity repeated exposure
No 24: Guidance document on acute oral toxicity testing
No 21: Detailed review paper: Appraisal of test methods for sex hormone disrupting chemicals
No 20: Guidance document for neurotoxicity testing
No 19: Guidance document on the recognition, assessment and use of clinical signs as humane endpoints
No 16: Detailed review document on classification systems for skin irritation/corrosion in OECD Member Countries
No 15: Detailed review document on classification systems for reproductive toxicity in OECD Member Countries
No 14: Detailed review document on classification systems for eye irritation/corrosion in OECD Member Countries
No 13: Detailed review document on classification systems for sensitising substances in OECD Member Countries
No 12: Detailed review document on classification systems for germ cell mutagenicity in OECD Member Countries
ENV Monograph No 36: Scientific criteria for validation of in vitro toxicity tests Pages 1-31; Pages 32-62
This publication is also available in French: Part 1; Part 2
Final Report of the OECD Workshop on Harmonization of Validation and Acceptance Criteria for Alternative Toxicological Test Methods (1996)
ENGAGE WITH US
Related Documents